全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Neuromyelitis Optica Spectrum Disorders in Africa (A Narrative Review of 622 Cases)

DOI: 10.4236/oalib.1109649, PP. 1-11

Subject Areas: Neurology

Keywords: Neuromyelitis Optica Spectrum Disorders, CNS, Aquarporin-4, Antibodies, Africa

Full-Text   Cite this paper   Add to My Lib

Abstract

Neuromyelitis Optica spectrum disorders (NMOSD) are a group of inflammatory disorders of the CNS, characterized by severe attacks of optic neuritis and myelitis. There are very few epidemiological studies of NMOSD in Africa. The purpose is to provide descriptive details of all cases published and reported in scientific meetings, analyze epidemiological, clinical, paraclinical, therapeutic, and outcome profiles of NMOSD in Africa and compare our data with literature. Authors did a literature search using MEDLINE, EMBASE, SCIENCE DIRECT, and GOOGLE SCHOOLAR. The search further extended to international and local journals, as well as regional and national meetings for all reports and articles about NMOSD in Africa. Till the end of 2019, 622 cases were reported in Africa, originating from 21 countries. The average age at disease onset was 32.5 years and the women to men ratio was 2.78:1. The big majority of patients underwent both brain MRI and serum aquarporin-4 antibody testing. The prognosis was generally unfavorable, with motor and/or visual sequelae. This 1st report of NMOSD in Africa does not reflect reality; theoretical number is around 50,000 cases, due certainly to considerable gap with many under-diagnosed and certainly misdiagnosed cases, due to many factors.

Cite this paper

Kissani, N. , Ouadika, R. J. B. , Kishk, N. A. , Chaymae, O. , Ibrahim, E. A. A. , Maiga, Y. , Paul, R. , Daniel, G. M. , Hamid, A. , Assogba, K. , Gaye, N. M. , Hor, J. Y. , Tegueu, C. K. , Marignier, R. , Palace, J. , Weinshenker, B. G. , Ragab, A. H. and Fujihara, K. (2022). Neuromyelitis Optica Spectrum Disorders in Africa (A Narrative Review of 622 Cases). Open Access Library Journal, 9, e9649. doi: http://dx.doi.org/10.4236/oalib.1109649.

References

[1]  Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B.G. (2000) Multiple Sclerosis. The New England Journal of Medicine, 343, 938-952. https://doi.org/10.1056/NEJM200009283431307
[2]  Galetta, S.L. and Bennett, J. (2007) Neuromyelitis Optica Is a Variant of Multiple Sclerosis. Archives of Neurology, 64, 901-903. https://doi.org/10.1001/archneur.64.6.901
[3]  Lana-Peixoto, M.A. and Callegaro, D. (2012) The Expanded Spectrum of Neuromyelitis Optica: Evidences for a New Definition. Arquivos de Neuro-Psiquiatria, 70, 807-813. https://doi.org/10.1590/S0004-282X2012001000010
[4]  Lalive, P.H., Chofflon, M. and Luc, P. (2007) Neuromyélite optique/syndrome de Devic: Avancées et perspectives. Revue Médicale Suisse, 7, 950-955. https://www.revmed.ch/RMS/2007/RMS-106/31872
[5]  Moriguchi, K. , Miyamoto, K. , Ichihashi, J. and Kusunoki, S. (2013) Autoantibodies against Myelin Antigens in Patients with Neuromyelitis Optica. Open Journal of Immunology, 3, 41-46. https://doi.org/10.4236/oji.2013.32007
[6]  Guo, Y., Weigand, S. D., Popescu, B. F., Lennon, V. A., et al. (2017) Pathogenic Implications of Cerebrospinal Fluid Barrier Pathology in Neuromyelitis Optica. Acta Neuropathologica, 133, 597-612. https://doi.org/10.1007/s00401-017-1682-1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348570/
[7]  Takeshita, Y., Obermeier, B., Cotleur, A.C., et al. (2017) Effects of Neuromyelitis Optica-IgG at the Blood-Brain Barrier in Vitro. Neurology: Neuroimmunology & Neuroinflammation, 4, e311. https://doi.org/10.1212/NXI.0000000000000311
[8]  Bennis, A., El Otmani, H., Benkirane, N., et al. (2019) Clinical Course of Neuromyelitis Optica Spectrum Disorder in a Moroccan Cohort. Multiple Sclerosis and Related Disorders, 30, 141-148. https://doi.org/10.1016/j.msard.2019.02.012
[9]  Dallal, T., Larabi, K., Abassi, Y., Mebrouk, Y., Mabrouki, F.Z., Chariba, S. and Sekhsoukh, R. (2020) Profil clinique et étiologique des neuropathies optiques inflammatoire au CHU d’Oujda, à propos de 52 cas. Revue neurologique, 176, 16. https://doi.org/10.1016/j.neurol.2020.01.087
[10]  El Otmani, H., Rafai, M.A., Moutaouakil, F., et al. (2005) La neuromyélite optique au Maroc: étude de neuf cas. Revue Neurologique, 161, 1191-1196. https://doi.org/10.1016/S0035-3787(05)85192-6
[11]  Merazga, M., Alipacha, L., Nouioua, S., Beghdadi, K., Amel, S. and Tazir, M. (2018) Neuromyélite optique de Devic séropositive à neuro-imagerie normale. Revue Neurologique, 174, S28-S29. https://doi.org/10.1016/j.neurol.2018.01.065 https://www.em-consulte.com/article/1205990/article/neuromyelite-optique-de-devic-seropositive-a-neuro
[12]  Oumerzouk, J., Hsaini, Y., Jouhari, A., et al. (2012) La maladie de Devic et atteinte encéphalique: à propos d’un cas. Revue Neurologique, 168, 381-383. https://doi.org/10.1016/j.neurol.2011.08.015 https://www.em-consulte.com/article/707591/figures/la-maladie-de-devic-et-atteinte-encephalique-a-pro
[13]  Bencherifa, F., Bourassi, A., Mellal, Z. and Berraho, A. (2008) Neuromyélite optique de Devic survenue au cours d’une grossesse Devic’s neuro-optic myelitis and pregnancy. Journal Français d’Ophtalmologie, 30, 737-743. https://doi.org/10.1016/S0181-5512(07)91363-7 https://www.em-consulte.com/en/article/132894
[14]  Kissani, N., Cherkaoui Rhazouani, O., Berrhoute, L., Chraa, M. and Louhab, N. (2021) An Update on Epidemiology, Diagnosis & Management of NMO-SD in the Tertiary Neurology Department of Marrakech (Morocco). Revue Neurologique, 177, 80-84. https://doi.org/10.1016/j.neurol.2020.05.006 https://www.em-consulte.com/article/1378868/an-update-on-epidemiology-diagnosis-a-management-o
[15]  Farid, Z., Nadia, M., Hichem, B., Mohamed, B. and Faycel, M. (2014) Du vomissement incoercible à la neuromyélite de Devic. Revue Neurologique, 170, A50. https://doi.org/10.1016/j.neurol.2014.01.107 https://www.em-consulte.com/en/article/878974
[16]  Daoudi, S. and Bouzar, M. (2016) Neuromyelitis Optica Spectrum Disorders in Algeria: A Preliminary Study in the Region of Tizi Ouzou. Multiple Sclerosis and Related Disorders, 6, 37-40. https://doi.org/10.1016/j.msard.2015.12.005
[17]  Komolafe, M.A., Komolafe, E.O., Sunmonu, T.A., et al. (2008) New Onset Neuromyelitis Optica in a Young Nigerian Woman with Possible Antiphospholipid Syndrome: A Case Report. Journal of Medical Case Reports, 2, Article No. 348. https://doi.org/10.1186/1752-1947-2-348
[18]  Kishk, N., Ragab, A.H., Shalaby, N. and Shehata, H. (2019) Demographics and Clinical Characteristics of Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Egypt: A First Retrospective Longitudinal Study in a Tertiary Referral Center. ECTRIMS 2019, Stockholm, Sweden, 11-13 September 2019.
[19]  Salama, S., Marouf, H., Ihab Reda, M., et al. (2018) Clinical and Radiological Characteristics of Neuromyelitis Optica Spectrum Disorder in the North Egyptian Nile Delta. Journal of Neuroimmunology, 324, 22-25. https://doi.org/10.1016/j.jneuroim.2018.08.014
[20]  Hift, W. and Moodley, T. (1973) A Possible Case of Neuromyelitis Optica in a Bantu Patient. South African Medical Journal, 47, 987-988.
[21]  Gaye, N.M., Fall, M., Diop, A.M., et al. (2019) Neuromyelitis Optica Spectrum Disorders (NMO-SD) in a Sub-Saharan Africa Country: A Preliminary Study of Sixteen Senegalese Cases. Multiple Sclerosis and Related Disorders, 27, 179-183. https://doi.org/10.1016/j.msard.2018.10.108
[22]  Kchaou, M., Mohamed, M., Ali Nadia, B., et al. (2016) Emergence de la NMO à Ac anti-aquaporine positifs en Tunisie: 3 observations et formes trompeuses. Revue Neurologique, 172, A89. https://doi.org/10.1016/j.neurol.2016.01.215
[23]  Fatma, N., Jeridi, C., et al. (2018) Neuromyélitie optique (NMO) et spectre NMO (SNMO): Caractéristiques cliniques, radiologiques et évolutives d’une série Tunisienne. Revue Neurologique, 174, S156. https://doi.org/10.1016/j.neurol.2018.01.358 https://www.em-consulte.com/article/1205872/neuromyelitie-optique-nmo-et-spectre-nmo-snmo-car
[24]  Bhigjee, A.I., Moodley, A.A., Roos, I., et al. (2017) The Neuromyelitis Optica Presentation and the Aquaporin-4 Antibody in HIV-Seropositive and Seronegative Patients in KwaZulu-Natal, South Africa. Southern African Journal of HIV Medicine, 18, a684. https://doi.org/10.4102/sajhivmed.v18i1.684
[25]  Maiga, Y., Traoré, I., et al. (2016) La neuromyélite optique (NMO) au Mali: Quelle réalité ? Revue Neurologique, 172, A79. https://doi.org/10.1016/j.neurol.2016.01.190 https://www.em-consulte.com/article/1040207/article/la-neuromyelite-optique-nmo-au-mali-quelle-realit
[26]  Kumako, V.K., Apetse, K., Assogba, K., Belo, M. and Balogou, A.A.K. (2019) Les affections du spectre de la neuromyelite optique sontelles vraiment rares en Afrique noire? à propos de deux cas documentes au TOGO. Revue Neurologique, 175, S26. https://doi.org/10.1016/j.neurol.2019.01.095 https://www.em-consulte.com/en/article/1283962
[27]  Ye, D., Lougue, C., Meda, N., et al. (1999) Acute Optic Neuromyelitis or Devic Syndrome in a Six-Year-Old Child in Burkina Faso. Med Trop (Mars), 59, Article No. 413.
[28]  Kadjo, C., Yapo-Ehounoud, C., Kouakou, J., et al. (2019) La neuromyelite optique (NMO) en Côte d’Ivoire: A propos d’un cas confirmé. African Journal of Neurological Sciences, 38, 54-59.
[29]  Kaddumukasa, M., Musubire, A., Kaddumukasa, M., Matovu, S. and Katabira, E. (2013) Neuromyelitis Optica in a Ugandan Woman: A Case Report. Journal of Medical Case Reports, 7, Article No. 177. https://doi.org/10.1186/1752-1947-7-177
[30]  Srikugan, L., Loganayagam, A. and Kelleher, K. (2010) A Case of Optic Neuritis and Transverse Myelitis in a Postpartum Ghanaian Female. Journal of Hospital Medicine, 5, E12-E13. https://doi.org/10.1002/jhm.398
[31]  Daouda, M.T., Obenda, N.S., Assadeck, H., Camara, D. and Djibo, F.H. (2016) Traitement de la neuromyélite optique de Devic durant de la grossesse. Pan African Medical Journal, 24, Article 230. https://doi.org/10.11604/pamj.2016.24.230.9167
[32]  Mbonda, E., Larnaout, A., Maertens, A., et al. (1990) Multiple Sclerosis in a Black Cameroonian Woman. Acta Neurologica Belgica, 90, 218-222.
[33]  Bugeme, M., Affognon, K.C.C., Asta, K.D., Mourabit, S. and Mukuku, O. (2017) Neuromyelitis Optica with Negative Anti-Aquaporin-4 Antibodies: About an Observation. Clinical Neurology and Neuroscience, 1, 104-106.
[34]  Blanche, P., Diaz, E., Gombert, B. and Sicard, D. (2000) Devic’s Neuromyelitis Optica and HIV-1 Infection. Journal of Neurology, Neurosurgery & Psychiatry, 68, 795-796. https://doi.org/10.1136/jnnp.68.6.795a
[35]  Ibrahim, E.A.A., Gammer, F. and Gassoum, A. (2020) Neuromyelitis Optica: A Pilot Study of Clinical Presentation and Status of Serological Biomarker AQP4 among Patients Admitted to a Tertiary Centre in NCNS, Sudan. BMC Neuroscience, 21, Article No. 9. https://doi.org/10.1186/s12868-020-0557-x
[36]  Flanagan, E.P., Cabre, P., Weinshenker, B.G., et al. (2016) Epidemiology of Aquaporin-4 Autoimmunity and Neuromyelitis Optica Spectrum. Annals of Neurology, 79, 775-783. https://doi.org/10.1002/ana.24617
[37]  Hor, J.Y., Asgari, N., Nakashima, I., et al. (2020) Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide. Frontiers in Neurology, 11, Article 501. https://doi.org/10.3389/fneur.2020.00501
[38]  Wu, L., Huang, D., Yang, Y. and Wu W. (2014) Combined Screening for Serum Anti-Nuclear and Anti-Aquaporin-4 Antibodies Improves Diagnostic Accuracy for Distinguishing Neuromyelitis Optica from Multiple Sclerosis. European Neurology, 72, 103-108. https://doi.org/10.1159/000358218
[39]  Marrie, R.A. and Gryba, C. (2013) The Incidence and Prevalence of Neuromyelitis Optica. International Journal of MS Care, 15, 113-118. https://doi.org/10.7224/1537-2073.2012-048
[40]  Cabre, P., Gonzalez-Quevedo, A., Lannuzel, A., et al. (2009) épidémiologie descriptive de la neuromyélite optique dans le bassin caraïbéen [Descriptive Epidemiology of Neuromyelitis Optica in the Caribbean Basin]. Revue Neurologique, 165, 676-683. https://doi.org/10.1016/j.neurol.2009.02.012
[41]  Asgari, N., Lillevang, S.T., Skejoe, H.P.B., et al. (2011) A Population-Based Study of Neuromyelitis Optica in Caucasians. Neurology, 76, 1589-1595. https://doi.org/10.1212/WNL.0b013e3182190f74
[42]  Jarius, S., Ruprecht, K., Wildemann, B., et al. (2012) Contrasting Disease Patterns in Seropositive and Seronegative Neuromyelitis Optica: A Multicentre Study of 175 Patients. Journal of Neuroinflammation, 9, Article No. 14. https://doi.org/10.1186/1742-2094-9-14
[43]  Mealy, M., Wingerchuk, D.M., Greenberg, B.M. and Levy, M. (2012) Epidemiology of Neuromyelitis Optica in the United States a Multicenter Analysis. Archives of Neurology, 69, 1176-1180. https://doi.org/10.1001/archneurol.2012.314
[44]  Hummers, L.K., Krishnan, C., Casciola-Rosen, L., et al. (2004) Recurrent Transverse Myelitis Associates with Anti-Ro (SSA) Autoantibodies. Neurology, 62, 147-149. https://doi.org/10.1212/01.WNL.0000101715.32569.1A

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413